Found: 7
Select item for more details and to access through your institution.
Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1373367
- By:
- Publication type:
- Article
Suppression of critical temperature and superfluid phase stiffness by magnetic Ni and nonmagnetic Zn in Y<sub>3</sub>Ba<sub>5</sub>Cu<sub>8</sub>O<sub>18–δ</sub> superconductors.
- Published in:
- Applied Physics A: Materials Science & Processing, 2023, v. 129, n. 11, p. 1, doi. 10.1007/s00339-023-07049-3
- By:
- Publication type:
- Article
Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.893921
- By:
- Publication type:
- Article
IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2021.624310
- By:
- Publication type:
- Article
Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB).
- Published in:
- Toxins, 2019, v. 11, n. 6, p. 339, doi. 10.3390/toxins11060339
- By:
- Publication type:
- Article
A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System.
- Published in:
- Toxins, 2018, v. 10, n. 9, p. 377, doi. 10.3390/toxins10090377
- By:
- Publication type:
- Article
Fusion Toxin BLyS-Gelonin Inhibits Growth of Malignant Human B Cell Lines In Vitro and In Vivo.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0047361
- By:
- Publication type:
- Article